Cookie Consent by Privacy Policies Generator website SEHA Introduces Novel Treatment to Better Support Adults With Depression : GoDubai.com
GoDubai
  
  
  
  
Citylife > Press Release
  Home Contact us Add to Favourites
Most Recent Postings
More Press Releses
Featured Sections

Latest Dubai Press Releases >>

    Share

Abu Dhabi, October 09, 2021:   Abu Dhabi Health Services Company, (SEHA) – the UAE's largest healthcare network, has recently introduced Esketamine nasal spray for the treatment and management of severe depression in adults who have tried other antidepressant treatment modalities, but have seen little or no benefit (otherwise known as treatment-resistant depression).
 
Esketamine targets new receptors in the brain than those which were traditionally addressed by antidepressant medications. It has shown good safety profile and tolerability in patients. In line with the network's mission to provide patients with world-class medical care, SEHA has introduced this novel therapy for patients experiencing treatment-resistant depression. It will be administered as nasal spray under medical supervision at Psychiatry clinics in AHS and Psychiatry outpatient clinics at SKMC and AAH. 
 
Dr. Nahida Niaz Ahmed, Consultant Psychiatrist and Chair of Behavioural Health Council at SEHA, said: “At SEHA, our goal has always been to provide our patients with highest standards in treatment. Our team of highly experienced psychiatrists and psychologists strive to deliver a holistic and integrated treatment modality, tailored for each individual patient. Mental health and its treatment differ from patient to patient, which is why we are pleased to add another treatment method to our services, giving us more bandwidth to explore treatment solutions that are as tailored to each patient as possible.”
 
A number of patients recently shared their experience after receiving the treatment, highlighting how Esketamine has facilitated their recovery.

A 30-year-old man, who has been struggling with major depressive disorder for the past six years, was prescribed Esketamine after trying multiple types of medication, anti-depressants and even shock therapy (ECT) all of which were unsuccessful in relieving him of his depression. A month after his physician started him on the nasal spray, he began to notice a positive impact on his outlook and lifestyle – now he exercises daily, is comfortable socially interacting, and has become significantly more motivated to find a job and support his family.

Similarly, a 20-year-old woman, diagnosed with severe depression and who was suicidal at times, gained no relief from previous medication. The nasal spray helped improve her condition and significantly decreased her suicidal thoughts.
 
Another young man who had isolated himself in his room and stopped studies for over three years, adversely effecting his physical and mental health, now after receiving the new treatment he resumed school and aims to enrol in college. He has gradually been able to deal with negative thoughts and replaced them with goals and ambitions for a better future. 
 
In line with the network's aim to provide world-class healthcare to the community, SEHA boasts an extensive array of specialties and departments prepared to treat patients with mental health, including telemedicine services, mobile clinics specialized psychiatric clinics, and home care by community mental health services, to provide diagnostic and therapeutic services for senior citizens and those with chronic illnesses.



Posted by : GoDubai Editorial Team
Viewed 9385 times
Posted on : Saturday, October 9, 2021  
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of GoDubai.com.
Previous Story : Sheikh Shakhbout Medical City Focuses on Holistic Care This Breast Cancer Awareness Month
Next Story : Otology, Neurotology and Skull Base Surgery to be discussed at Dubai Otology Next Week
Email this article Print this article

Share this article with your friends and followers
NewsVine

Comments

Back to Top  
Most Viewed Press Release posted in the last 7 days